T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.29% |
| 2 | Technology | 17.01% |
| 3 | Financials | 16.32% |
| 4 | Consumer Discretionary | 14.01% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMS
1401
DELISTED
Bemis
BMS
| $6.29M | ﹤0.01% |
131,603
+17,290
| +15% | +$799K |
|
1402
Warner Bros
WBD
$69.6B
| $6.28M | ﹤0.01% |
280,640
+15,200
| +6% | +$297K |
|
1403
Berkshire Hathaway Class A
BRK.A
$1.09T
| $6.25M | ﹤0.01% |
21
| – | – |
|
1404
Annaly Capital Management
NLY
$17.6B
| $6.18M | ﹤0.01% |
130,033
+2,584
| +2% | +$123K |
|
|
HAPN
1405
Happen Inc
HAPN
$2.27B
| $6.17M | ﹤0.01% |
298,619
+5,660
| +2% | +$141K |
|
|
FPRX
1406
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $6.16M | ﹤0.01% |
+281,207
| New | +$9.04M |
|
1407
CALL
Sysco
SYY
$40.5B
| $6.07M | ﹤0.01% |
100,000
| – | – |
|
1408
Travere Therapeutics
TVTX
$5.79B
| $6.03M | ﹤0.01% |
286,201
-60,500
| -17% | -$1.38M |
|
1409
iRhythm Holdings
IRTC
$4.06B
| $5.94M | ﹤0.01% |
105,949
-64,983
| -38% | -$3.4M |
|
1410
Navient
NAVI
$867M
| $5.87M | ﹤0.01% |
440,773
-108,270
| -20% | -$1.37M |
|
|
TVRD
1411
Tvardi Therapeutics
TVRD
$22.1M
| $5.87M | ﹤0.01% |
13,311
+637
| +5% | +$290K |
|
|
SRT
1412
DELISTED
Startek Inc.
SRT
| $5.69M | ﹤0.01% |
570,293
-103,670
| -15% | -$1.12M |
|
|
JMP
1413
DELISTED
JMP Group LLC
JMP
| $5.68M | ﹤0.01% |
1,014,112
-23,000
| -2% | -$126K |
|
|
CHK
1414
DELISTED
Chesapeake Energy Corporation
CHK
| $5.65M | ﹤0.01% |
7,136
-158
| -2% | -$123K |
|
1415
Cheniere Energy
LNG
$55B
| $5.6M | ﹤0.01% |
104,085
-5,430
| -5% | -$262K |
|
1416
Powell Industries
POWL
$7.43B
| $5.59M | ﹤0.01% |
585,192
-20,700
| -3% | -$198K |
|
|
MOMO
1417
Hello Group
MOMO
$867M
| $5.56M | ﹤0.01% |
+227,257
| New | +$6.55M |
|
|
ESV
1418
DELISTED
Ensco Rowan plc
ESV
| $5.51M | ﹤0.01% |
233,226
+175,536
| +304% | +$3.89M |
|
|
CRAY
1419
DELISTED
Cray, Inc.
CRAY
| $5.42M | ﹤0.01% |
224,188
-120,499
| -35% | -$2.55M |
|
|
YELL
1420
DELISTED
Yellow Corporation Common Stock
YELL
| $5.38M | ﹤0.01% |
374,409
-274,260
| -42% | -$3.61M |
|
|
P
1421
Everpure Inc
P
$39B
| $5.3M | ﹤0.01% |
334,381
-978,451
| -75% | -$16.3M |
|
|
SMPLW
1422
DELISTED
The Simply Good Foods Company Warrant
SMPLW
| $5.26M | ﹤0.01% |
1,355,499
-124,368
| -8% | -$340K |
|
1423
Lear
LEA
$8.16B
| $5.2M | ﹤0.01% |
29,454
-2,306
| -7% | -$405K |
|
1424
Paycom
PAYC
$9.52B
| $5.2M | ﹤0.01% |
64,714
-8,334
| -11% | -$667K |
|
1425
Liberty Media Series C
FWONK
$26B
| $5.17M | ﹤0.01% |
156,419
+106,936
| +216% | +$3.86M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.